Mode-of-Action Studies of the Novel Bisquaternary Bisnaphthalimide MT02 againstStaphylococcus aureus

OpuC – an ABC Transporter that is Associated with Staphylococcus Aureus Pathogenesis

(2018) Madanahally D. Kiran et al.   INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS

The bisnaphthalimides as new active lead compounds against Plasmodium falciparum

(2010) Maximilian Tischer et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Resistance to Linezolid Is Mediated by thecfrGene in the First Report of an Outbreak of Linezolid‐ResistantStaphylococcus aureus

(2010) Gracia Morales et al.   CLINICAL INFECTIOUS DISEASES

Repair of Global Regulators in Staphylococcus aureus 8325 and Comparative Analysis with Other Clinical Isolates

(2010) S. Herbert et al.   INFECTION AND IMMUNITY

Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer

(2009) M. Doyle et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era

(2009) Frank R. DeLeo et al.   JOURNAL OF CLINICAL INVESTIGATION

Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid

(2009) Koichiro Yoshida et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Indirect Effects Modulating the Interaction between DNA and a Cytotoxic Bisnaphthalimide Reveal a Two-Step Binding Process

(2009) Luis González-Bulnes et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Novel antibiotics for the treatment ofStaphylococcus aureus

(2009) Knut Ohlsen   Expert Review of Clinical Pharmacology